DiaMedica Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DMAC Nasdaq 2836 www.diamedica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - Jun 24th, 2025 6:30 am
With 39% ownership, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) insiders have a lot riding on the company's future - May 28th, 2025 6:26 am
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 - May 22nd, 2025 6:30 am
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia - May 19th, 2025 7:00 am
DiaMedica Therapeutics Inc (DMAC) Q1 2025 Earnings Call Highlights: Strong Financial Position ... - May 15th, 2025 1:09 am
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 - May 14th, 2025 2:30 pm
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights - May 13th, 2025 2:30 pm
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May - May 8th, 2025 2:00 pm
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025 - May 7th, 2025 6:30 am
We're Hopeful That DiaMedica Therapeutics (NASDAQ:DMAC) Will Use Its Cash Wisely - Apr 25th, 2025 7:14 am
DiaMedica Therapeutics Inc (DMAC) Q4 2024 Earnings Call Highlights: Strong Financial Position ... - Mar 19th, 2025 1:00 am
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results - Mar 17th, 2025 2:30 pm
Insider Stock Buying Reaches US$9.00m On DiaMedica Therapeutics - Mar 17th, 2025 5:44 am
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025 - Mar 11th, 2025 6:23 am
DiaMedica Therapeutics Appoints Daniel J. O’Connor to the Board of Directors - Feb 24th, 2025 6:30 am
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke - Feb 20th, 2025 6:15 am
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 10th, 2025 2:15 pm
Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m - Dec 19th, 2024 4:34 am
DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia - Dec 3rd, 2024 6:25 am
We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate - Nov 16th, 2024 5:51 am